The Vitligo and Pigmentation Institute of Southern California is hosting part of the trial to evaluate Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea vs Placebo. This trial is looking to prove changes in inflammatory markers like the peptide LL-37 and the MMP family match the improvement seen when taking Oracea.
The trial is scheduled to involve 170 participants at multiple centres. If you are able to attend the Los Angeles clinic as detailed below, you will be compensated and may even end up receiving free Oracea during the trial.
From Pearl E Grimes, M.D. Clinical Trials
Do you suffer from Rosacea?
Dr. Pearl E. Grimes, Medical Director of the Vitiligo & Pigmentation Institute of Southern California, is nationally and internationally recognized for her research work. The institute is conducting a clinical study for rosacea.
If you are between the ages of 18 and 70 and have a red face with at least 5 but no more than 40 papules and/or pustules, you may be eligible to participate in this study. Involvement in this study may last up to 13 weeks.
All qualified participants will receive all study-related care and either oral medication or placebo at no cost, and will be compensated for time, participation and travel.
Are you interested?
If you are interested, please contact:
Kali Ghazali, CRC
Vitiligo & Pigmentation Institute of Southern California
5670 Wilshire Blvd, Suite 650
Los Angeles, CA 90036
t: (323) 467-4389 ext 6
e: Research@pearlgrimesmd.com
